Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Data storage device with surface ornamentation
Real-time RSL monitoring in a web-based application
Non-visual presentation of information on an electronic wireless device
PMI feedback with codebook interpolation
Image capture and identification system and process
Luminescent substrate for liciferase
Device for increasing chip testing efficiency and method thereof
  Randomly Featured Patents
Single crystal turbine components made using a moving zone transient liquid phase bonded sandwich construction
Centralized fuel tank submersible pump control
Offset voltage compensation circuit
Mixed ethylene alpha olefin copolymer multifunctional viscosity modifiers useful in lube oil compositions
Amplitude-shift-keying (ASK) envelope detector and demodulation circuits
Method and apparatus for controlling engine speed of a self-propelled power trowel during high load conditions
Cutting insert and a cutting tool assembly incorporating such an insert
Tuck box with header card
Array architecture and operation for high density magnetic racetrack memory system
Method of performing reliable updates in a symmetrically blocked nonvolatile memory having a bifurcated storage architecture